Extended-release Pharmacotherapy for Opioid Use Disorder (EXPO): Protocol for an Open-Label Randomised Controlled Trial of the Effectiveness and Cost-Effectiveness of Injectable Buprenorphine Versus Sublingual Tablet Buprenorphine and Oral Liquid Methadone
Trials(2022)
Key words
Opioid use disorder,Long-acting injectable buprenorphine,Extended-release buprenorphine,Psychosocial intervention,Randomised controlled trial
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined